SNRPB promotes cell cycle progression in thyroid carcinoma via inhibiting p53.

Abstract

Papillary thyroid carcinoma (PTC) accounts for more than 80% of all thyroid carcinoma cases. Small nuclear ribonucleoprotein polypeptides B and B1 (SNRPB) has been indicated to be carcinogenic in several cancers; however, its function and mechanism in PTC are unclarified. Real time quantitative polymerase chain reaction and western blotting revealed the upregulation of SNRPB and downregulation of tumor protein p53 in PTC tissues compared with the normal tissues. Flow cytometry and western blotting displayed that SNRPB silencing induced cell cycle arrest at G1 phase and suppressed the expression levels of Cyclin family proteins in PTC cells. In vivo experiments suggested that SNRPB silencing inhibited PTC tumor growth in mice. Bioinformatics analysis revealed that the expression of SNRPB and cell cycle-associated genes in thyroid carcinoma tissues is positively correlated. Immunofluorescence staining and co-immunoprecipitation demonstrated that SNRPB directly interacted with p53 and suppressed its expression in PTC cells. In conclusion, SNRPB facilitates cell cycle progression in PTC by inhibiting p53 expression.

• Authors: Yan Deng, Xin Li, Wenlei Jiang, Jindan Tang
• Journal: Open medicine (Warsaw, Poland) (Open Med (Wars)) Vol. 17 Issue 1 Pg. 1623-1631 ( 2022) ISSN: 2391-5463 [Print] Poland
• PMID: 36329787 (Publication Type: Journal Article)
• Copyright: © 2022 Yan Deng et al., published by De Gruyter.